Total Payments
$2,872
2024 Payments
$798.52
Companies
17
Transactions
108
Medicare Patients
777
Medicare Billing
$42,679
Payment Breakdown by Category
Food & Beverage$2,872 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,872 | 108 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $903.14 | 36 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $530.49 | 12 | $0 (2024) |
| Novo Nordisk Inc | $411.81 | 13 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $240.16 | 10 | $0 (2022) |
| Lilly USA, LLC | $163.77 | 3 | $0 (2022) |
| Exact Sciences Corporation | $123.70 | 6 | $0 (2024) |
| PFIZER INC. | $93.22 | 5 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $87.37 | 5 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $76.16 | 4 | $0 (2023) |
| Phathom Pharmaceuticals, Inc. | $52.28 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $798.52 | 32 | ABBVIE INC. ($316.62) |
| 2023 | $531.76 | 24 | ABBVIE INC. ($314.92) |
| 2022 | $1,303 | 50 | ABBVIE INC. ($271.60) |
| 2021 | $238.39 | 2 | Novo Nordisk Inc ($122.78) |
All Payment Transactions
108 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Respiratory | ||||||
| 08/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.40 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Oncology | ||||||
| 07/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Oncology | ||||||
| 06/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Respiratory | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $121.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $86.43 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/26/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Oncology | ||||||
| 03/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Respiratory | ||||||
| 03/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 79 | 89 | $15,925 | $6,200 |
| 2022 | 4 | 164 | 195 | $30,723 | $13,711 |
| 2021 | 20 | 534 | 2,036 | $87,833 | $22,768 |
Total Patients
777
Total Services
2,320
Medicare Billing
$42,679
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 78 | $13,560 | $5,030 | 37.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 11 | 11 | $2,365 | $1,170 | 49.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 86 | $15,023 | $6,140 | 40.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 35 | 35 | $7,525 | $3,839 | 51.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 63 | $7,746 | $3,412 | 44.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $429.00 | $319.37 | 74.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 52 | $16,536 | $4,932 | 29.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 48 | $8,739 | $3,089 | 35.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 55 | 55 | $8,575 | $2,822 | 32.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $9,810 | $2,315 | 23.6% |
| 87811 | Sars-cov-2 covid19 w/optic | Office | 2021 | 41 | 41 | $6,425 | $1,697 | 26.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 12 | $5,159 | $1,466 | 28.4% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 22 | 22 | $3,218 | $1,323 | 41.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 16 | 16 | $5,133 | $1,297 | 25.3% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2021 | 13 | 13 | $3,510 | $1,245 | 35.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 19 | 19 | $2,126 | $856.09 | 40.3% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 28 | 28 | $5,969 | $612.56 | 10.3% |
| 80047 | Blood test, basic group of blood chemicals (calcium, ionized) | Office | 2021 | 31 | 31 | $2,027 | $385.88 | 19.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 20 | 21 | $1,548 | $172.26 | 11.1% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2021 | 13 | 1,445 | $2,168 | $137.23 | 6.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 13 | 13 | $1,599 | $130.26 | 8.1% |
| 81002 | Urinalysis, manual test | Office | 2021 | 32 | 32 | $960.00 | $111.36 | 11.6% |
| 85014 | Red blood cell concentration measurement | Office | 2021 | 29 | 29 | $1,637 | $62.15 | 3.8% |
| 85018 | Blood count, hemoglobin | Office | 2021 | 29 | 29 | $1,594 | $62.15 | 3.9% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2021 | 20 | 22 | $220.00 | $44.12 | 20.1% |
About Ann Cribbin
Ann Cribbin is a Family healthcare provider based in Ballwin, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/05/2021. The National Provider Identifier (NPI) number assigned to this provider is 1215529870.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ann Cribbin has received a total of $2,872 in payments from pharmaceutical and medical device companies, with $798.52 received in 2024. These payments were reported across 108 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,872).
As a Medicare-enrolled provider, Cribbin has provided services to 777 Medicare beneficiaries, totaling 2,320 services with total Medicare billing of $42,679. Data is available for 3 years (2021–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Ballwin, MO
- Active Since 02/05/2021
- Last Updated 02/05/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1215529870
Products in Payments
- VRAYLAR (Drug) $696.33
- BREZTRI (Drug) $337.78
- NURTEC ODT (Drug) $240.16
- Ozempic (Drug) $163.58
- FARXIGA (Drug) $136.95
- MOUNJARO (Drug) $123.71
- Cologuard Collection Kit (Device) $123.70
- RYBELSUS (Drug) $122.78
- UBRELVY (Drug) $111.39
- QULIPTA (Drug) $95.42
- Rybelsus (Drug) $92.01
- ELIQUIS (Drug) $77.45
- Livalo (Drug) $75.45
- AIRSUPRA (Drug) $55.76
- VOQUEZNA (Drug) $52.28
- QUVIVIQ (Drug) $45.53
- SOLIQUA 100/33 (Biological) $42.37
- Natesto (Drug) $36.36
- TOUJEO (Biological) $33.79
- TRULICITY (Drug) $24.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Ballwin
Alexandra Hof
Family — Payments: $1,999
Family $1,999
Ms. Jennifer Giltner, Fnp-C, FNP-C
Family — Payments: $1,122
Family $1,122
Ms. Christina Blaesing, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C
Family — Payments: $981.58
Family $981.58
Reni Joseph, Fnp, FNP
Family — Payments: $794.15
Family $794.15
Amina Spijodic, Fnp-C, FNP-C
Family — Payments: $525.34
Family $525.34
Mrs. Lindsey Mccarthy, Fnp, FNP
Family — Payments: $415.36
Family $415.36